Acurian Expands Partnership with Society for Clinical Research Sites

Ellicott City, MD, August 23, 2017 – The Society for Clinical Research Sites (SCRS) today announced an expanded relationship with Acurian, Inc., the leading full-service provider of global patient enrollment and retention solutions and a subsidiary of Pharmaceutical Product Development, LLC (PPD). As a Site Engagement Partner, Acurian will continue to participate on the SCRS Global Impact Board, which works closely with SCRS’ Leadership Council to provide advice on strategic initiatives.

Acurian will also host a Site Advocacy Group (SAG) focused on oncology to gain access to the expertise and insights of SCRS members who have deep knowledge of challenges that can hinder enrollment and retention success. In addition, Acurian will serve as corporate sponsor for Hungary and Poland in the SCRS Ambassador program.

“Acurian’s increased commitment as a sponsor of the SCRS Ambassador program and SAG host demonstrates their recognition of the importance of site sustainability,” said Christine Pierre, President of SCRS. “We look forward to working together through this expanded partnership to cultivate global clinical trial success.”

“Acurian is excited to continue our partnership with SCRS and our commitment to global site sustainability,” said Todd Albin, Senior Director of Site Enrollment Optimization at Acurian. “Our involvement in these impactful initiatives provides Acurian with the valuable insights needed from key site stakeholders around the world. It is through these engagements that Acurian is able to understand how to best support the evolving site enrollment and patient engagement needs in today’s challenging site environment.”

 

About Acurian
Acurian, a subsidiary of PPD, is a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry. The company increases the enrollment performance of investigator sites worldwide by identifying, contacting, prescreening and referring people who live in the local community but are unknown to a research site. As a result, trial sponsors complete enrollment without incurring the unexpected expense of adding sites or time. For more information, visit www.acurian.com.

About PPD

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 47 countries and more than 19,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health. For more information, visit www.ppdi.com.

About SCRS
SCRS is a global trade organization founded in 2012 which represents almost 9,000 research sites in over 45 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Our Voice. Our Community. Your Success. Join the community and collaborate with the global experts in site sustainability. Visit MySCRS.org.

Contact:
Mary D’Rozario
Director of Communications
Society for Clinical Research Sites
919.890.5513
mary.drozario@myscrs.org

###